Looks like you have JavaScript disabled. For the full Twine experience, you will need to re-enable it.

I’m Marcus Stüttgen, a strategic pharma and biotech executive with over 25 years of experience across Infectious Diseases & Vaccines, Hematology/Oncology, CNS/Psychiatry and Pain. I help global and local teams shape portfolio strategy, drive launches, and transform commercial capabilities through pragmatic leadership, cross-functional collaboration, and agile practices. Today I work as an interim manager and independent consultant, delivering strategic and operational marketing support, go-to-market planning, and executional excellence for pharma and biotech clients, with a focus on sustainable growth and risk minimization.…I’m Marcus Stüttgen, a strategic pharma and biotech executive with over 25 years of experience across Infectious Diseases & Vaccines, Hematology/Oncology, CNS/Psychiatry and Pain. I help global and local teams shape portfolio strategy, drive launches, and transform commercial capabilities through pragmatic leadership, cross-functional collaboration, and agile practices. Today I work as an interim manager and independent consultant, delivering strategic and operational marketing support, go-to-market planning, and executional excellence for pharma and biotech clients, with a focus on sustainable growth and risk minimization.

Marcus Stuettgen

Marketing Strategist, Brand Strategist, Project Manager, +2





I’m Marcus Stüttgen, a strategic pharma and biotech executive with over 25 years of experience across Infectious Diseases & Vaccines, Hematology/Oncology, CNS/Psychiatry and Pain. I help global and local teams shape portfolio strategy, drive launches, and transform commercial capabilities through pragmatic leadership, cross-functional collaboration, and agile practices. Today I work as an interim manager and independent consultant, delivering strategic and operational marketing support, go-to-market planning, and executional excellence for pharma and biotech clients, with a focus on sustainable growth and risk minimization.…I’m Marcus Stüttgen, a strategic pharma and biotech executive with over 25 years of experience across Infectious Diseases & Vaccines, Hematology/Oncology, CNS/Psychiatry and Pain. I help global and local teams shape portfolio strategy, drive launches, and transform commercial capabilities through pragmatic leadership, cross-functional collaboration, and agile practices. Today I work as an interim manager and independent consultant, delivering strategic and operational marketing support, go-to-market planning, and executional excellence for pharma and biotech clients, with a focus on sustainable growth and risk minimization.

Available to hire

I’m Marcus Stüttgen, a strategic pharma and biotech executive with over 25 years of experience across Infectious Diseases & Vaccines, Hematology/Oncology, CNS/Psychiatry and Pain. I help global and local teams shape portfolio strategy, drive launches, and transform commercial capabilities through pragmatic leadership, cross-functional collaboration, and agile practices.

Today I work as an interim manager and independent consultant, delivering strategic and operational marketing support, go-to-market planning, and executional excellence for pharma and biotech clients, with a focus on sustainable growth and risk minimization.

Skills

Data Visualization

Experience Level

Data Visualization

Intermediate

Language

German

Fluent

English

Fluent

French

Intermediate

Spanish; Castilian

Intermediate

Work Experience

Freelance Consultant – Strategic & Operational Marketing at Independent / Freelance

October 1, 2025 - Present

Strategic and operational marketing support for pharma and biotech clients; go-to-market planning; launch execution; interim leadership; agile transformation; cross-functional team development.

Global Director Strategic Marketing COVID-19 and RSV Vaccines & Vaccine portfolio at J&J, Janssen GCSO

January 1, 2020 - December 31, 2024

Defined and executed the global commercial strategy for COVID-19 and RSV vaccines and the broader portfolio. Led a 20-member cross-functional team across Commercial, Medical, Regulatory and Market Access; aligned global and regional stakeholders to maximize launch performance and market penetration.

Global Director Strategic Marketing Lead ID&V/Respiratory at J&J, Janssen GCSO

January 1, 2019 - December 31, 2020

Developed global strategy for Influenza/Pimodivir in alignment with DAS Respiratory Infections strategy. Led a cross-functional and highly matrixed Global Commercial Team.

Strategic Pioneers Team Lead EMEA (IBVTL) at J&J, Janssen EMEA

January 1, 2018 - December 31, 2019

Shaped early-stage asset strategies in RSV & Influenza vaccines, Ponesimod (MS), and Imetelstat (Hematology/Oncology) across EMEA. Led a cross-functional EMEA team (Marketing, Regulatory, Medical Affairs, Market Access, BI).

International Brand Value Team Lead Respiratory EMEA at J&J, Janssen EMEA

January 1, 2015 - December 31, 2018

Directed EMEA brand strategy and tactical execution for RSV and Influenza across 50+ markets. Delivered operational excellence and regional alignment in highly matrixed environments.

Director New Business Development and Innovation Management at J&J, Janssen Germany

January 1, 2011 - December 31, 2015

Closed strategic deals and integrated Crucell operations into broader business. Led multiple NBD functions across country and regional franchise levels.

Director Marketing TA CNS/Chronic Pain at J&J, Janssen Germany

January 1, 2005 - December 31, 2011

Led and executed the launch of Jurnista; managed strategic and operational marketing for the pain portfolio (Jurnista, Durogesic, Anesthetics) with full P&L responsibility. Built and led a high-performing marketing team, collaborating closely with Medical, Market Access and Sales.

Marketing Manager Pain US at J&J, Janssen US

January 1, 2004 - December 31, 2005

Led marketing activities and projects for the pain portfolio in the US market.

Product Manager CNS/Psychiatry and Neurology (Risperdal) at J&J, Janssen Germany

January 1, 2003 - December 31, 2004

Led the launch of the bipolar disorders indication for Risperdal; developed product strategy, lifecycle management and cross-functional collaboration.

Product Manager Dermatology (Sporanox) at J&J, Janssen Germany

January 1, 1992 - December 31, 2003

Product management in Dermatology; marketing activities and cross-functional collaboration.